Optimizing Tobacco Treatment Delivery for People Living With HIV
Who can join
Ages 21 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 21 and older * Current diagnosis of HIV * Current smoker (defined as self-report of current smoking) * Willing to be randomized * English speaking Exclusion Criteria: * Currently taking part in any other tobacco treatment program or using cessation medication (i.e., taking nicotine replacement therapy or other cessation medications, enrolled in the Quitline, or in another study) * Currently imprisoned * Pregnant women * Non-English speaking persons
About the study
The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate implementation outcomes to identify barriers and facilitators towards future implementation. Investigators hope to define best practices and optimize the delivery of smoking cessation interventions for people living with HIV.
What is being tested
- PrOMOTE (behavioral)
Sponsor: Medical University of South Carolina · Participants: 231 · Started: Dec 1, 2021
Contact the study team
- Chloe Morone · Phone: 843-637-0734
- Alana Rojewski · Phone: 8438761593
Official record on ClinicalTrials.gov — NCT05019495
Locations in the U.S.
| South Carolina | Medical University of South Carolina, Charleston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.